Damora Therapeutics (DMRA) Accounts Payables (2019 - 2026)
Damora Therapeutics' Accounts Payables came in at $3.48 million for Q2 2026, up 360.6% from $756,000 a year earlier and up 325.2% from the prior quarter.
Powered by 
Analysis
Damora Therapeutics (DMRA) Accounts Payables (2019 - 2026) Analysis & Trends
At the end of FY2025, Damora Therapeutics' Accounts Payables was $444,000, up 17.8% from FY2024.
- Accounts Payables carries a five-year compound annual growth rate of -31.1% (FY2020 to FY2025).
- Going back by year, Accounts Payables was $377,000 in FY2024 (-77.8%), $1.7 million in FY2023 (-49.2%), $3.35 million in FY2022 (+118.8%) and $1.53 million in FY2021 (-46.3%).
- The Q2 2026 figure represents the highest quarterly Accounts Payables since Q3 2023.
- Year-over-year, Accounts Payables has increased for five consecutive quarters, with growth averaging 34.0% over the last eight quarters.
- The fastest year-over-year change in Accounts Payables over five years came in Q2 2026 (growth of 360.6%), and the weakest in Q3 2024 (a decline of 88.8%).
- Business Quant data shows DMRA's Accounts Payables at $819,000 (Q1 2026), $444,000 (Q4 2025) and $520,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 6.11 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 9.32 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 33.30 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 3.83 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 4.26 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 22.89 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 2.87 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 674.00 Mn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 4.58 Bn |
| 10 | Damora Therapeutics | 1.32 Bn | -14.46 Mn | - | 3.48 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.48 Mn |
| Mar 31, 2026 | 819,000.00 |
| Dec 31, 2025 | 444,000.00 |
| Sep 30, 2025 | 520,000.00 |
| Jun 30, 2025 | 756,000.00 |
| Mar 31, 2025 | 354,000.00 |
| Dec 31, 2024 | 377,000.00 |
| Sep 30, 2024 | 503,000.00 |
| Jun 30, 2024 | 724,000.00 |
| Mar 31, 2024 | 1.67 Mn |
| Dec 31, 2023 | 1.70 Mn |
| Sep 30, 2023 | 4.48 Mn |
| Jun 30, 2023 | 5.56 Mn |
| Mar 31, 2023 | 3.55 Mn |
| Dec 31, 2022 | 3.35 Mn |
| Sep 30, 2022 | 1.91 Mn |
| Jun 30, 2022 | 2.82 Mn |
| Mar 31, 2022 | 3.22 Mn |
| Dec 31, 2021 | 1.53 Mn |
| Sep 30, 2021 | 1.98 Mn |
API Access
Damora Therapeutics Accounts Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accounts-payables&ticker=DMRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accounts-payables", "ticker": "DMRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accounts-payables&ticker=DMRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();